Monitoring and assessing the pharmaceutical sector are vital to determine if the key pharmaceutical objectives are met: people have access to essential medicines, these medicines are safe, effective and of good quality, and they are used correctly. A systematic method to assess and monitor the impact of strategies and activities will provide information on issues and gaps, all-important input in the development of health policies. The WHO process for pharmaceutical monitoring and assessment uses a hierarchical approach with three groups of indicators: Level I, Level II and Level III. This provides a standard methodology to follow progress over time and to compare situations in different facilities, districts and countries...